相关实验视频

Updated: Jan 6, 2026

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

工程外细胞囊泡用于治疗炎症疾病

Yiran Lu¹, Shizhi Wang², Bingjia Yu³

¹Key Laboratory of Environmental Medicine & Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.

Molecular biotechnology

|November 18, 2025

概括

细胞外囊泡 (EVs) 提供卓越的生物相容性和向性输送,用于治疗炎症疾病. 工程电动汽车提高治疗效率,减少治疗时间,降低医疗费用,为传统疗法提供了有希望的替代方案.

科学领域:

生物医学工程生物医学工程
免疫学免疫学免疫学
纳米医学是一种纳米医学.

背景情况:

与炎症相关的疾病对全球健康造成重大负担,影响医疗保健系统和社会经济发展.
目前用于炎症疾病的治疗方法在有效性和安全性方面存在局限性,需要新的治疗方法.
细胞外囊泡 (EVs) 正因其固有的优势而成为有前途的治疗剂.

研究的目的:

审查细胞外囊泡 (EVs) 在治疗炎症疾病中的治疗潜力.
总结一下EV用于特定炎症疾病的最新进展.
讨论基于EV的疗法临床翻译的挑战和前景.

主要方法:

关于细胞外囊泡 (EV) 在炎症疾病中的应用现有文献的综述.
分析用于治疗干预的原生和工程电动汽车的优势.
检查EV功能化战略,以有针对性地提供生物活性成分.

主要成果:

本地电动汽车表现出卓越的生物相容性,结构完整性,以及在炎症条件下穿透屏障.
工程电动汽车可以功能化,以有针对性的传递miRNA和蛋白质来调节炎症途径.
基于EV的疗法显示出提高疗效,缩短治疗时间和降低医疗保健成本的潜力.

结论:

细胞外囊泡 (EVs) 代表了炎症疾病的有前途的治疗策略,比传统治疗提供了优势.
功能化的EV能够精确调节炎症信号,从而改善患者的治疗结果.
解决临床翻译挑战对于实现EVs在炎症疾病中的全部治疗潜力至关重要.

关键词:

药物输送是药物输送的过程.工程设计的细胞外囊泡.炎症炎症是一种炎症.目标化目标化目标化目标化治疗方法治疗方法

更多相关视频

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants

Labeling of Extracellular Vesicles for Monitoring Migration and Uptake in Cartilage Explants

Published on: October 4, 2021

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...